Hui Yang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Intellectual Disability

Endoplasmic Reticulum

Top Venues

Signal transduction and targeted therapy

Cell death discovery

Cell death & disease

Cancer biology & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuheng Liao, Hui Yang
Metabolic regulation of innate immunity in cancer immunotherapy. Cancer biology & medicine 20 (12) (2024)
Yuheng Liao, Hui Yang
Metabolic regulation of innate immunity in cancer immunotherapy. Cancer biology & medicine 20 (12) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Xiongzhi Lin, Dongsheng Sun, Shuhan Yang, Kai Cheng, XingYi Wang, Weijia Meng, Haowei Wu, Wenlin Liu, Xiaoyu Wu, Hui Yang, Xiaojun Wang, Lisha Zhou
UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell death & disease 15 (8) (2024)
Xiongzhi Lin, Dongsheng Sun, Shuhan Yang, Kai Cheng, XingYi Wang, Weijia Meng, Haowei Wu, Wenlin Liu, Xiaoyu Wu, Hui Yang, Xiaojun Wang, Lisha Zhou
UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell death & disease 15 (8) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Yuheng Liao, Hui Yang
Metabolic regulation of innate immunity in cancer immunotherapy. Cancer biology & medicine 20 (12) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Xiongzhi Lin, Dongsheng Sun, Shuhan Yang, Kai Cheng, XingYi Wang, Weijia Meng, Haowei Wu, Wenlin Liu, Xiaoyu Wu, Hui Yang, Xiaojun Wang, Lisha Zhou
UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell death & disease 15 (8) (2024)
Ankang Hu, Li Sun, Hao Lin, Yuheng Liao, Hui Yang, Ying Mao
Harnessing innate immune pathways for therapeutic advancement in cancer. Signal transduction and targeted therapy 9 (1) (2024)
Jiaxin Li, Rui Zhang, Changwan Wang, Junyan Zhu, Miao Ren, Yingbo Jiang, Xianteng Hou, Yangting Du, Qing Wu, Shishi Qi, Lin Li, She Chen, Hui Yang, Fajian Hou
Author Correction: WDR77 inhibits prion-like aggregation of MAVS to limit antiviral innate immune response. Nature communications 14 (1) (2023)
Lisha Zhou, Xiongzhi Lin, Jin Zhu, Luyi Zhang, Siyuan Chen, Hui Yang, Lijun Jia, Baofu Chen
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell death discovery 9 (1) (2023)
Jiaxin Li, Rui Zhang, Changwan Wang, Junyan Zhu, Miao Ren, Yingbo Jiang, Xianteng Hou, Yangting Du, Qing Wu, Shishi Qi, Lin Li, She Chen, Hui Yang, Fajian Hou
WDR77 inhibits prion-like aggregation of MAVS to limit antiviral innate immune response. Nature communications 14 (1) (2023)
Wei Yuan, Qian Zhang, Danling Gu, Chenfei Lu, Deobrat Dixit, Ryan N Gimple, Yisu Gao, Jiancheng Gao, Daqi Li, Danyan Shan, Lang Hu, Lu Li, Yangqing Li, Shusheng Ci, Hao You, Linping Yan, Kexin Chen, Ningwei Zhao, Chuanhai Xu, Jianyun Lan, Dong Liu, Junxia Zhang, Zhumei Shi, Qiulian Wu, Kailin Yang, Linjie Zhao, Zhixin Qiu, Deguan Lv, Wei Gao, Hui Yang, Fan Lin, Qiang-Hu Wang, Jianghong Man, Chao-Jun Li, Weiwei Tao, Sameer Agnihotri, Xu Qian, Stephen C Mack, Nu Zhang, Yongping You, Jeremy N Rich, Guan Sun, Xiuxing Wang
Dual role of CXCL8 in maintaining the mesenchymal state of glioblastoma stem cells and M2-like tumor-associated macrophages. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lisha Zhou, Xiongzhi Lin, Jin Zhu, Luyi Zhang, Siyuan Chen, Hui Yang, Lijun Jia, Baofu Chen
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell death discovery 9 (1) (2023)
Qiyuan Zhuang, Ying Liu, Hanze Wang, Ziyang Lin, Li Sun, Yue Liu, Yingying Lyu, Liang Chen, Hui Yang, Ying Mao
LILRB3 suppresses immunity in glioma and is associated with poor prognosis. Clinical and translational medicine 13 (10) (2023)
Lisha Zhou, Xiongzhi Lin, Jin Zhu, Luyi Zhang, Siyuan Chen, Hui Yang, Lijun Jia, Baofu Chen
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell death discovery 9 (1) (2023)
Daqi Li, Qian Zhang, Lu Li, Kexin Chen, Junlei Yang, Deobrat Dixit, Ryan N Gimple, Shusheng Ci, Chenfei Lu, Lang Hu, Jiancheng Gao, Danyang Shan, Yangqing Li, Junxia Zhang, Zhumei Shi, Danling Gu, Wei Yuan, Qiulian Wu, Kailin Yang, Linjie Zhao, Zhixin Qiu, Deguang Lv, Wei Gao, Hui Yang, Fan Lin, Qiang-Hu Wang, Jianghong Man, Chaojun Li, Weiwei Tao, Sameer Agnihotri, Xu Qian, Yu Shi, Yongping You, Nu Zhang, Jeremy N Rich, Xiuxing Wang
β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages. Cancer research 82 (18) (2022)
Qi Liu, Fangming Zhu, Xinnan Liu, Ying Lu, Ke Yao, Na Tian, Lingfeng Tong, David A Figge, Xiuwen Wang, Yichao Han, Yakui Li, Yemin Zhu, Lei Hu, Yingning Ji, Nannan Xu, Dan Li, Xiaochuan Gu, Rui Liang, Guifang Gan, Lifang Wu, Ping Zhang, Tian-Le Xu, Hui Hu, Ze-Ping Hu, Huji Xu, Dan Ye, Hui Yang, Bin Li, Xue-Mei Tong
Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics. Nature metabolism 4 (5) (2022)
Xiufei Chen, Wenjie Zhou, Ren-Hua Song, Shuang Liu, Shu Wang, Yujia Chen, Chao Gao, Chenxi He, Jianxiong Xiao, Lei Zhang, Tianxiang Wang, Peng Liu, Kun-Long Duan, Zhouli Cheng, Chen Zhang, Jinye Zhang, Yiping Sun, Felix Jackson, Fei Lan, Yun Liu, Yanhui Xu, Justin Jong-Leong Wong, Pu Wang, Hui Yang, Yue Xiong, Tong Chen, Yan Li, Dan Ye
Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity. Science advances 8 (4) (2022)
Lei-Lei Chen, Carmen Morcelle, Zhou-Li Cheng, Xiufei Chen, Yan-Ping Xu, Yajing Gao, Junbin Song, Zhijun Li, Matthew D Smith, Miao Shi, Yezhang Zhu, Neng Zhou, Meng Cheng, Chenxi He, Kwei-Yan Liu, Guoping Lu, Lei Zhang, Cheng Zhang, Jin-Ye Zhang, Yiping Sun, Tuan Qi, Yingying Lyu, Zhi-Zhong Ren, Xian-Ming Tan, Jiayong Yin, Fei Lan, Ying Liu, Hui Yang, Maoxiang Qian, Caiwen Duan, Xing Chang, Yufeng Zhou, Li Shen, Albert S Baldwin, Kun-Liang Guan, Yue Xiong, Dan Ye
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nature cell biology 24 (3) (2022)
Hao Chen, Hao Chen, Jia-Min Zhang, Yumin Wang, Antoine Simoneau, Hui Yang, Arthur S Levine, Lee Zou, Zhijian J Chen, Li Lan
cGAS suppresses genomic instability as a decelerator of replication forks. Science advances 6 (42) (2020)